Tag: special
-
Precision Medicine, “My Hope for the Future”
A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure.
-
Patent Office Decides for Broad and Editas in Crispr Case
The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley.
-
Science Org. CEO: Trump Order “Contrary to Science”
The chief executive officer of the world’s largest general science organization called the Trump administration’s order detaining travelers from Muslim countries to the U.S., including scientists and students, “contrary to the spirit of science.”
-
News Blackout Imposed on U.S. Science Agencies [Updated]
Multiple news services today are reporting that the Trump administration is ordering several U.S. government agencies conducting or funding scientific research to cease discussing its activities with the media or public officials.
-
Report from Maker Faire: Wrist Band Takes Blood Pressure
Report from Maker Faire: Two students designed a blood-pressure measurement device worn on the wrist to provide continuous readings, something a cuff cannot do.
-
Report from Maker Faire: Plastic Recycling Made in Space
Report from Maker Faire: Made In Space and Lowe’s stores displayed a system that recycles polyethylene plastic bags and bottles into filament for 3-D printers.
-
Another Chance to Get Serious on Drug Pricing
Stephen Ubl, president and CEO of Pharmaceutical Research and Manufacturers of America, or PhRMA, told a press and industry event in Washington, D.C. on Wednesday (25 May) that drug makers are eager to develop more individualized treatments for patients, but proposed regulations on drug pricing threaten that progress. Ubl also suggested, however, at the Annual…
-
Drug Pricing Reform Even Big Pharma Might Like
2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription drug prices, took aim at drug companies and their business practices. “An unaffordable drug is 100 percent ineffective,” Doggett told an audience at Center for American Progress on 26 April. He noted that…
-
Special: The Next Health Care Disruption
– Sponsored Content – This blog post is part of the ‘Think Further’ series sponsored by Fred Alger Management. For more “Think Further” content, please visit www.thinkfurtheralger.com.” The frustration of the physicians comes through, piercing the structured format of a scientific journal. In July 2015, 118 oncologists at leading medical centers and cancer research institutes…
-
Cancer Specialists Offer Plan to Reduce Drug Prices
23 July 2015. A group of 118 cancer specialists proposed steps to reduce the cost of drugs to cancer patients, calling the current system of drug pricing “unsustainable and not affordable for many patients.” Their recommendations appear today in a commentary published in the journal Mayo Clinic Proceedings. Pharmaceutical industry representatives, however, say drugs play…